News & Updates

Show Multimedia Only

Add-on orforglipron improves outcomes in T2D patients on insulin glargine

Daily treatment with oral orforglipron, when added to titrated insulin glargine, has been shown to be beneficial in individuals with inadequately controlled type 2 diabetes (T2D) in the phase 3 ACHIEVE-5 trial.

Add-on orforglipron improves outcomes in T2D patients on insulin glargine

15 hours ago

Tirzepatide superior to ICC in metformin-resistant T2D

16 hours ago

Treatment with tirzepatide yields robust reductions in HbA1c, weight, and waist circumference in patients with early type 2 diabetes (T2D) uncontrolled with metformin, reports a study.

Tirzepatide superior to ICC in metformin-resistant T2D

16 hours ago

Weight, income status modify impact of extreme temperature events on daily step counts

14 Jun 2026

Individuals with low income or high BMI appear to be more vulnerable to heatwaves, while those with low income or normal BMI tend to have greater sensitivity during cold spells, both of which contribute to fewer daily step counts, suggests a study.

Weight, income status modify impact of extreme temperature events on daily step counts

14 Jun 2026

Rapid response to obesity medications tied to greater weight loss

09 Jun 2026 by

A post hoc analysis of the SURMOUNT-5 study reveals more tirzepatide-treated individuals with obesity achieving all body weight (BW) reduction thresholds than semaglutide-treated participants, with rapid responders showing a greater magnitude of weight loss.

Rapid response to obesity medications tied to greater weight loss

09 Jun 2026

Glycaemic control in T2D better with CGM vs self-monitoring

08 Jun 2026 by

In adult patients with type 2 diabetes (T2D) receiving basal insulin alongside other glucose-lowering medications, real-time continuous glucose monitoring (CGM) demonstrates superiority over self-monitoring of blood glucose (SMBG) in terms of optimizing glycaemic control, according to the FreeDM2 study.

Glycaemic control in T2D better with CGM vs self-monitoring

08 Jun 2026

High choline, betaine intakes may improve cognitive performance in older adults with obesity

08 Jun 2026 by

Regular intake of dietary choline and betaine results in moderate short-term improvements in cognitive function and helps prevent cognitive decline in older adults with overweight or obesity and metabolic syndrome (MetS), reveals a study.

High choline, betaine intakes may improve cognitive performance in older adults with obesity

08 Jun 2026

Low-insulinemic, planetary health diets good for weight management during menopause

06 Jun 2026

For menopausal women, adopting low-insulinemic and planetary health diets—rich in nuts, legumes, fruits, vegetables, and whole grains and low in red or processed meats, sodium, and French fries—helps optimize weight and long-term cardiometabolic health, as shown in a study.

Low-insulinemic, planetary health diets good for weight management during menopause

06 Jun 2026

Physical activity intensity matters more for chronic disease prevention

05 Jun 2026 by

Prioritizing physical activity (PA) intensity over volume may yield greater benefits for preventing most noncommunicable diseases (NCDs), a prospective study suggests.

Physical activity intensity matters more for chronic disease prevention

05 Jun 2026

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

05 Jun 2026

Treatment with bempedoic acid helps lower low‐density lipoprotein cholesterol (LDL‐C) levels in Asian patients who have LDL-C elevations despite receiving lipid-lowering therapy, including statins, according to a study from Taiwan.

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

05 Jun 2026

Sustained adherence to growth hormone therapy boosts growth outcomes in children

04 Jun 2026

Children maintaining a sustained adherence rate of at least 85 percent to daily growth hormone therapy see a clinically meaningful improvement in growth over 2 years, as shown in a retrospective study.

Sustained adherence to growth hormone therapy boosts growth outcomes in children

04 Jun 2026

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Add-on orforglipron improves outcomes in T2D patients on insulin glargine

Add-on orforglipron improves outcomes in T2D patients on insulin glargine

Tirzepatide superior to ICC in metformin-resistant T2D

Tirzepatide superior to ICC in metformin-resistant T2D

Weight, income status modify impact of extreme temperature events on daily step counts

Weight, income status modify impact of extreme temperature events on daily step counts

Rapid response to obesity medications tied to greater weight loss

Rapid response to obesity medications tied to greater weight loss

Glycaemic control in T2D better with CGM vs self-monitoring

Glycaemic control in T2D better with CGM vs self-monitoring

High choline, betaine intakes may improve cognitive performance in older adults with obesity

High choline, betaine intakes may improve cognitive performance in older adults with obesity

Low-insulinemic, planetary health diets good for weight management during menopause

Low-insulinemic, planetary health diets good for weight management during menopause

Physical activity intensity matters more for chronic disease prevention

Physical activity intensity matters more for chronic disease prevention

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

Sustained adherence to growth hormone therapy boosts growth outcomes in children

Sustained adherence to growth hormone therapy boosts growth outcomes in children